The OligoSynergy project is led by GU Ventures and funded by Interreg Öresund-Kattegat-Skagerrak and Region Västra Götaland. According to the organisations, it is aimed at early-stage companies in the preclinical and early clinical phases, with a focus on the development, validation and commercialisation of their technologies, products and services.
BII and GU Ventures collaborate on oligonucleotide project
Denmark’s BioInnovation Institute (BII) and Sweden’s GU Ventures are collaborating through a new cross-border project focused on therapeutic oligonucleotides.
Advertisement
BREAKING